<DOC>
	<DOC>NCT01481675</DOC>
	<brief_summary>To evaluate and compare prospectively the effects of Biliopancreatic Diversion Long Limb (BPDLL) and Laparoscopic Sleeve Gastrectomy (LSG) on resolution of diabetes mellitus type 2.</brief_summary>
	<brief_title>Diabetes Resolution and Hormone Changes After BPDLL and LSG</brief_title>
	<detailed_description>Twelve patients with diabetes mellitus type 2 (DM 2) and body mass index (BMI)&gt; 50kg/m2) will undergo BPDLL and 12 twelve patients with DM 2 and BMI 40-50 kg/m2 will undergo LSG. The patients will be evaluated before and 1, 3 and 12 months after surgery with an oral glucose tolerance test. The investigators aim to investigate the effects of surgery on diabetes resolution, hypertension, dyslipidemia, and also on fasting, and glucose-stimulated insulin, glucagon, ghrelin, peptide-YY and glucagon-like peptide-1 (GLP-1) responses during during an oral glucose tolerance test (OGTT). Resolution of diabetes mellitus will be evaluated according to the criteria of American Diabetes Association with an OGTT. The effects on appetite and satiety will be also evaluated with the use of visual analog scores.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>BMI&gt;50kg/m2 to undergo BPDLL BMI 4050kg/m2 to undergo LSG Diabetes mellitus type 2 Chronic medical illness Psychiatric illness Substance abuse Previous gastrointestinal surgery</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>biliopancreatic diversion</keyword>
	<keyword>sleeve gastrectomy</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>weight loss</keyword>
	<keyword>ghrelin</keyword>
	<keyword>PYY</keyword>
	<keyword>GLP-1</keyword>
</DOC>